Showing posts with label CPE. Show all posts
Showing posts with label CPE. Show all posts

Thursday, December 2, 2010

Some Facts about Eye Drops

On 28th November 2010, I attended the CPD Pharmacists' Workshop on Ophthalmology at the Saujana Hotel with several friends. This workshop is a breath of fresh air indeed-while the lunch is sponsored by Allergan, the workshop is not heavily laden with product talks; not only that, the invited speakers comprise consultant ophthalmologist and experienced pharmacists, sharing practical points on various topics:red eyes, dry eye, glaucoma and nutritional supplments for age-related macular disease.

Some learning points from the workshop that I would like to share with you all:
When instilling eye drops, 1 drop is sufficient as the ideal volume of a drop that the eye can hold, especially the conjunctiva cul de sac is 10-15uL and the typical volume of an eye drop is 40uL.

Sequence of instillation (if more than one type of topical drugs are to be used):
1) solution 2) suspension 3) Suspension/Gel

For contact lens wearer, instill the eye drop first, then wait for 15 minutes before putting on the contact lens.

Tear film is a barrier to effective drug delivery. Tear film penetration can be increased by manually blocking the nasolacrimal duct and tilting the head backwards. Occlusion of the nasolacrimal ducta after instillation of eye drop, minimises systemic absorption.Examples of systemic side effects: Gutt chloramphenicol may cause aplastic anaemia, Gutt timolol may cause acute exacerbation of bronchial asthma.


Once an eye drop passes the tear film, it penetrates the cornea which is the major site of absorption for topical drugs.

1 drop of eye drop: only 50% reach the site of action.

The iris acts as a reservoir for drugs instilled into the eye. Prostaglandin analogues used for glaucoma may change colour of iris as they stay in the iris.

Hydrophilic drugs do not enter the retina easily. They are prevented by tight junctions complexes at the retinal pigment epithelium, hence retinal toxicity is seen in certain drugs. E.g. Gutt. chloramphenicol may cause optic nerve toxicity.

Caution must be taken when recommending/prescribing steroid eye drops as they have contraindications and adverse effects. Adverse effects include: elevation of intraocular presure and possibly glaucoma with nerve damage, cataract formation, delayed wound healing, worsening corneal ulcers especially if bacterial or fungal.


One of the points to consider when recommending eye drop to patient-the types of preservatives used.


Tuesday, February 16, 2010

MPS 43rd AGM & Seminar

First of all, we would like to wish you all a very Happy Chinese New Year! May we soar to greater heights in the year of the Tiger =)

The Malaysian Pharmaceutical Society (MPS) is having its 43rd Annual General Meeting & Seminar with the theme
'Transcending Pharmacy to Greater Heights':

Date: 19/3/10 (Fri)-21/4/10(Sun)
Venue: Berjaya Times Square Hotel, K.L.

For
session 1 & 5, it is FREE for MPS members.
More information on seminar registration fees & registration procedure HERE


Here are the programmes at a glance:
19/3/10 (Fri)
Session 1: Extra Optional Programme

Lecture 1: Hypertension & Antihypertensives: How low can you go? How high can you give?
Lecture 2: Role of enoxaparin in surgical thromboprophylaxis
Lecture 3: Treating schizophrenia in the government setting-cost vs. outcomes
Lecture 4: Ideal basal insulin


20/3/10 (Sat)
Session 2: Updates in Paediatric Pharmacy (1)
Lecture 5: Roles of pharmacists in paediatric unit
Lecture 6: Common paediatric problems in Malaysia
Lecture 7: Special symposium
Lecture 8: Safe prescribing in children
Lecture 9: Pharmacists involvement in neonatal ICU
Lecture 10: Special symposium

Session 3: 43rd MPS Annual General Meeting
-Election of the new Council Members

7.30 p.m.-11.00 p.m.:
Annual Dinner


21/3/10 (Sun)
Session 4: Updates in Paediatric Pharmacy (2)
Lecture 11: Pharmacist involvement in paediatric oncology
Lecture 12: Clinical pharmacokinetic monitoring in paediatric
Lecture 13: Special symposium
Lecture 14: Special symposium
Lectuer 15: Pharmacist involvement in paediatric asthma
Lecture 16: Treatment of common skin problems in paediatric
Lecture 17: Special symposium


Sesssion 5: Building Community Pharmacy Practices
Lecture 18: Community pharmacy-where we are heading
Lecture 19: Sponsored symposium
Lecture 20: Pharmacy-oriented services in the community
Lecture 21: Staying competitive through networking

Saturday, January 2, 2010

CPD Talk: 24/4: A Revolution in Oral Contraception

Date: 10th January 2010
Time: 7.30 pm- 9.30 pm
Venue: KL Hilton,Kuala Lumpur.


The CPD talk will witness the launch of Bayer's new oral contraceptive (OC), YAZ, the first 20 mcg ethinylestradiol ultra low dose OC with 3 mg drospirenone in a unique 24/4 days regimen.


Yax is the only OC to be approved in Malaysia with 3 indications:

  1. Oral contraception
  2. Treatment of symptoms of premenstrual disorder
  3. Treatment of moderate acne


Agenda:

Time Program
7.30 pm Arrival of Guest & Registration
7.50 pm Opening Speech by Dr Shunitra Devi, Medical Director, Bayer Schering Pharma
8.00 pm Welcome address by Puan Faridah Yusof
8.10 pm " Oral Contraception: Past, Present and Future' by Prof Jamiyah Hassan
8.30 pm "24/4: A Revolution in Oral Contraception" Prof Lee P. Shulman
9.00 pm Q & A
9.20 pm

Launch Ceremony

9.30 pm Dinner


For RSVP, Kindly Contact: Ms Roseline Heng 03-6209 3151, Ms Rosmah 03- 6209 3162, Mr Daniel Quek 012-288 7449, Mr Daryl Chooy 012-320 3906

Friday, December 11, 2009

CPE Dinner Lecture: NSAIDs and COXIBs in 2010: Where do we Go From here?

Date: 19th December 2009 (Saturday)
Time: 7.00 pm- 8.30 pm
Venue: Sultan 1, Le Meridien Hotel, Kuala Lumpur


Speaker: Prof. Gurkirpal Singh, MD

Adjunct Clinical Professor of Medicine, Stanford University School of Medicine
Chief Science Officer, Institute of Clinical Outcomes Research adn Education Palo Alto, California


Below are some of the issues that Dr. Singh will elucidate in his presentation:

  • Does short-term use of NSAIDs increases risk of GI bleeds?
  • How can you identify patietns who are at a greater risk of GI bleeds? Dr. Singh has developde as imple six-item questionnaire which can predict future GI risk with about 90% accuracy.
  • Does COX-2 selectivity guarantees GI safety?
  • Is COX-2 selectivity associated with cardiovascular risk?
  • Is NSAID-induced hypertension clinically significant?


Agenda

Time

Program

7.00 pm-7.30 pm

Registration

7.30 pm-7.35 pm

Introduction by Chairperson

7.35 pm-8.15 pm

Lecture by Prof Gurkirpal Singh, MD

8.15 pm-8.30 pm

Q & A Session

8.30 pm

Dinner

RSVP by 16th December 2009 to Ms Hema at 03-5568 6688

Please indicate if Vegetarian food required.

1 CPE point will be awarded. For Healthecare Professional Only